云知声智能科技股份有限公司(简称“云知声”),一家专注于人工智能领域的独角兽企业,近日再次向资本市场发起冲击,更新招股书继续推进在香港联合交易所主板上市的计划。中金公司和海通国际被委任为联席保荐人,这标志着云知声在经历了2020年11月终止科创板上市申请后,再次尝试进入公开资本市场。
云知声成立以来,已经吸引了众多知名投资机构的关注,包括启明创投、挚信资本、磐谷创投、中网投、京东、中电健康基金、中金、360、高通等。这些资本的支持不仅展现了云知声在AI领域的潜力,也为其技术研发和市场拓展提供了强大的资金支持。
尽管云知声在资本市场上备受瞩目,但其招股书显示,公司累计亏损近5亿元。这一数字反映了AI企业在研发和市场拓展过程中的高昂成本。然而,云知声似乎并未因此减缓其发展步伐。2023年,公司发布了山海大模型,参数规模已经迭代至千亿级别。云知声计划将这一先进技术应用于智慧生活和智慧医疗领域,显示出其在AI技术商业化方面的雄心壮志。
云知声的港股IPO之路将是对其商业模式、技术实力和市场潜力的全面检验。随着人工智能技术的不断进步和应用场景的不断扩大,云知声的未来发展值得期待。
英文翻译内容:
Title: AI Unicorn Yunzhisheng Pushes for Hong Kong IPO with Capital from JD.com, 360
Keywords: Yunzhisheng, Hong Kong IPO, AI Unicorn, Losses, Capital Financing
News content:
Yunzhisheng Intelligent Technology, a leading player in the artificial intelligence (AI) sector, has once again taken steps towards public listing, updating its prospectus to continue its pursuit of a primary listing on the Main Board of the Hong Kong Stock Exchange. China International Capital Corporation (CICC) and Haitong International are acting as joint sponsors for the company, which had previously withdrawn its application to list on the Science and Technology Innovation Board (STAR Market) in November 2020.
Since its inception, Yunzhisheng has attracted significant attention from renowned investors such as Qiming Venture Partners, ZhenFund, Pangaea Venture Capital, China Internet Investment Fund (CIIF), JD.com, China Electronic Health Fund, CICC, 360, and Qualcomm. These investments not only highlight Yunzhisheng’s potential in the AI field but also provide substantial financial backing for its research and development and market expansion efforts.
Despite the attention in the capital market, Yunzhisheng’s prospectus reveals a cumulative loss of nearly 500 million yuan. This figure reflects the high costs associated with R&D and market expansion for AI companies. However, Yunzhisheng seems undeterred by these figures. In 2023, the company released the Shanhai AI model with a parameter scale that has since been iterated to the billion level. Yunzhisheng plans to apply this advanced technology to the smart life and smart healthcare sectors, demonstrating its ambition in the commercialization of AI technology.
The Hong Kong IPO journey for Yunzhisheng will be a comprehensive test of its business model, technological capabilities, and market potential. As AI technology advances and its applications expand, Yunzhisheng’s future development remains an exciting prospect to watch.
【来源】https://www.chinastarmarket.cn/detail/1622638
Views: 7